Nynomic (M7U) H2 2025 earnings summary

Executive summary

• Revenue declined 10% year-over-year to EUR 92.6 million, with EBIT dropping 73% to EUR 2.0 million, reflecting a challenging economic environment and restructuring costs.

• The NyFIT2025 efficiency programme was implemented, including intra-group mergers and cost optimizations, to strengthen future profitability and operational efficiency.

• Operational improvements were observed in the second half of the year, with a strong order backlog carried into 2026.

Financial highlights

• EBITDA decreased 37% to EUR 7.9 million; investments fell 28% to EUR 7.0 million.

• EPS before non-controlling interests was -0.05 EUR; after non-controlling interests, -0.11 EUR.

• Cash flow from operating activities was EUR 7.5 million, down 4% year-over-year.

• Equity ratio improved to 75.2% (up from 73.8%), with financial liabilities reduced by 37%.

Outlook and guidance

• For 2026, revenue is expected between EUR 100.0 million and EUR 105.0 million, with an EBIT margin of 6–8%.

• The company anticipates a return to profitable growth, supported by a robust order backlog and improved cost structure.